Shanghai Kehua Bio-Engineering Co Ltd
Shanghai Kehua Bio-Engineering Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sale of in vitro diagnostic reagents and medical testing equipment and services in China and internationally. The company offers immunoassay and clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management solution, and automated co… Read more
Shanghai Kehua Bio-Engineering Co Ltd (002022) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.008x
Based on the latest financial reports, Shanghai Kehua Bio-Engineering Co Ltd (002022) has a cash flow conversion efficiency ratio of 0.008x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.25 Million) by net assets (CN¥3.70 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai Kehua Bio-Engineering Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Shanghai Kehua Bio-Engineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shanghai Kehua Bio-Engineering Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Kehua Bio-Engineering Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Beijing SPC Environment Protection Tech Co Ltd
SHE:002573
|
0.049x |
|
Braskem S.A.
SA:BRKM3
|
0.215x |
|
TCI Co Ltd
TWO:8436
|
0.026x |
|
Hudson Pacific Properties Inc
NYSE:HPP
|
0.010x |
|
NOTE AB SK-50
F:NQA
|
N/A |
|
Chief Telecom Inc
TWO:6561
|
0.122x |
|
Momentum Group AB Series B
LSE:0RTK
|
0.040x |
|
China Western Power Industrial Co Ltd
SHE:002630
|
0.012x |
Annual Cash Flow Conversion Efficiency for Shanghai Kehua Bio-Engineering Co Ltd (2002–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Kehua Bio-Engineering Co Ltd from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.98 Billion | CN¥-50.12 Million | -0.013x | +86.79% |
| 2023-12-31 | CN¥4.98 Billion | CN¥-474.89 Million | -0.095x | -125.89% |
| 2022-12-31 | CN¥5.85 Billion | CN¥2.15 Billion | 0.368x | +74.98% |
| 2021-12-31 | CN¥5.13 Billion | CN¥1.08 Billion | 0.210x | -40.02% |
| 2020-12-31 | CN¥3.90 Billion | CN¥1.37 Billion | 0.351x | +279.08% |
| 2019-12-31 | CN¥2.69 Billion | CN¥248.87 Million | 0.093x | +77.28% |
| 2018-12-31 | CN¥2.43 Billion | CN¥126.79 Million | 0.052x | -17.01% |
| 2017-12-31 | CN¥2.08 Billion | CN¥130.71 Million | 0.063x | -57.51% |
| 2016-12-31 | CN¥1.90 Billion | CN¥281.25 Million | 0.148x | +13.84% |
| 2015-12-31 | CN¥1.73 Billion | CN¥224.30 Million | 0.130x | -34.00% |
| 2014-12-31 | CN¥1.27 Billion | CN¥249.64 Million | 0.197x | -4.92% |
| 2013-12-31 | CN¥1.21 Billion | CN¥250.22 Million | 0.207x | +5.27% |
| 2012-12-31 | CN¥1.09 Billion | CN¥213.74 Million | 0.197x | -8.18% |
| 2011-12-31 | CN¥1.03 Billion | CN¥219.80 Million | 0.214x | -17.48% |
| 2010-12-31 | CN¥931.34 Million | CN¥241.83 Million | 0.260x | -5.36% |
| 2009-12-31 | CN¥792.82 Million | CN¥217.51 Million | 0.274x | +28.29% |
| 2008-12-31 | CN¥643.75 Million | CN¥137.66 Million | 0.214x | -7.88% |
| 2007-12-31 | CN¥486.48 Million | CN¥112.93 Million | 0.232x | +5.95% |
| 2006-12-31 | CN¥398.02 Million | CN¥87.21 Million | 0.219x | +12.77% |
| 2005-12-31 | CN¥380.71 Million | CN¥73.97 Million | 0.194x | +52.22% |
| 2004-12-31 | CN¥381.82 Million | CN¥48.74 Million | 0.128x | -71.25% |
| 2003-12-31 | CN¥158.92 Million | CN¥70.57 Million | 0.444x | +56.53% |
| 2002-12-31 | CN¥146.21 Million | CN¥41.48 Million | 0.284x | -- |